Everybody deserves to feel the power of optimal health, and curcumin is one of the most powerful allies that we have found in nature to support total body health.
With a focus on developing the highest quality nutraceutical products founded on a robust body of scientific research, the team behind CurcuminPro® brings decades of scientific research and product development to the company so you too can “Feel The Feeling”™.
As a result, we’ve created the world’s first full line of curcumin-enhanced products by utilizing a groundbreaking patented and proprietary processes that promotes a BioSolube® curcumin delivery system for the whole body!
Through evidence-based science we have envelopedthe curcumin in a protein molecule or low glycemic sugar molecule, which created a super BioSoluble® and bio-available curcumin complex (CPRO®) that is up to 42X more water soluble than standard curcumin/turmeric supplements.
We make curcumin taste delicious! CPRO® is a taste and smell neutral curcumin complex that can be used in functional foods and beverages for animals and humans.
Whether it is our powerful CurcuminPro® capsules, our protein-boost shakes, or our sugar-free chocolatesand functional beverages, we take curcumin to a new level of effectiveness, and have opened the door to new types of products within the supplement industry.With all that being said, we’d like to take a few moments to introduce the driving force behind the company, the Executive Team and the Medical Advisory board.
Ron Gourley, Co-Founder, President, & CEO
Ron is an entrepreneurial visionary who has a unique talent for spotting impactful products that deserve a place to shine. He researches and has an unparalleled understanding of the science and the “why” behind his products, returning powerful, performance driven results.
His previous endeavor in sales and marketing at major food consumer product corporations including Hormel Foods, Oscar Mayer, and PepsiCo., enables Ron to understand his customers and relate to their needs. Ron values the end goal of a healthily, happy consumer, above all else, and has an unfaltering drive to deliver the best product backed by the best science.
His previous endeavor in sales and marketing at major food consumer product corporations including Hormel Foods, Oscar Mayer, and PepsiCo., enables Ron to understand his customers and relate to their needs. Ron values the end goal of a healthily, happy consumer, above all else, and has an unfaltering drive to deliver the best product backed by the best science.
Stacy Ray Allensworth, Co-Founder, Chief Operating Officer
Stacy has a dynamic background in entrepreneurial companies. Together with skills she learned managing tens of millions of dollars in operations from real estate to environmental to healthcare, she delivers a wealth of experience in day-to-day operations and executive vision for the company.
The depth of knowledge and experience that Stacy brings includes taking products from concept to market. She is skilled in negotiating raw material agreements, third party manufacturing contracts, graphics and labeling agreements, regulatory language, distribution logistics, and bookkeeping.
As a visionary who understands the exit value of the company, Stacy has unselfishly committed her talents and time for the ultimate success of the company. Her passion for the company, and the health of the people we strive to impact, are unparalleled.
The depth of knowledge and experience that Stacy brings includes taking products from concept to market. She is skilled in negotiating raw material agreements, third party manufacturing contracts, graphics and labeling agreements, regulatory language, distribution logistics, and bookkeeping.
As a visionary who understands the exit value of the company, Stacy has unselfishly committed her talents and time for the ultimate success of the company. Her passion for the company, and the health of the people we strive to impact, are unparalleled.
Ian O’Donnell, Vice President, Global Business Development
Ian O’Donnell is a twenty-year Consumer Goods and Industry veteran. He is currently the Director of Enterprise/CPG accounts at Google cloud. He was previously the Executive VP of Business Development for Accelerate360.
Before Accelerate360, Ian was the Sr Director of Industry for Microsoft Retail & CPG business covering national enterprise sales and leading Microsoft Retail & CPG go to market strategy at Industry shows and events. Ian held numerous executive positions at Mars Incorporated, including roles in Sales, Marketing, Finance, and Commercial. Ian was also the Sr. VP of Strategic Partnership for Compass Marketing, launching new products and services to market. Ian also has served on many industry committees, including the National Association of Convenience Stores (NACS), Food Marketing Institute (FMI), and the National Confectioners Association (NCA). Ian has a passion for Advising pioneer and start up brands achieve their success in retail.
Before Accelerate360, Ian was the Sr Director of Industry for Microsoft Retail & CPG business covering national enterprise sales and leading Microsoft Retail & CPG go to market strategy at Industry shows and events. Ian held numerous executive positions at Mars Incorporated, including roles in Sales, Marketing, Finance, and Commercial. Ian was also the Sr. VP of Strategic Partnership for Compass Marketing, launching new products and services to market. Ian also has served on many industry committees, including the National Association of Convenience Stores (NACS), Food Marketing Institute (FMI), and the National Confectioners Association (NCA). Ian has a passion for Advising pioneer and start up brands achieve their success in retail.
OUR MEDICAL ADVISORY BOARD
John E. Lewis, Ph.D. Medical Advisor
John E. Lewis, Ph.D. is past full-time and current Voluntary Associate Professor in the Department of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine and the Founder and President of Dr Lewis NutritionTMNutrition™ (https://www.drlewisnutrition.com/).
He is a Diplomate, Faculty Member, and Advisor of the Medical Wellness Association. He has been the principal investigator of over 30 different studies in his research career. During that time, he either directly raised or indirectly supported raising over $23 million in grants, gifts, and contracts for research studies and clinical trials and educational programs for medical students. Much of his research has focused on evaluating the effects of nutrition, dietary supplementation, exercise, and medical devices on various aspects of human health and disease.
He is a Diplomate, Faculty Member, and Advisor of the Medical Wellness Association. He has been the principal investigator of over 30 different studies in his research career. During that time, he either directly raised or indirectly supported raising over $23 million in grants, gifts, and contracts for research studies and clinical trials and educational programs for medical students. Much of his research has focused on evaluating the effects of nutrition, dietary supplementation, exercise, and medical devices on various aspects of human health and disease.
Dr. Harvey Kaltsas, Acupuncture Physician (FL), Dipl. Ac. (NCCAOM) Medical Advisor
Dr. Kaltsas is a 1969 graduate of Amherst College, a 1977 graduate of the New England School of Acupuncture, and in 2000 was awarded a Doctorate of Integrative Medicine from the Florida College of Integrative Medicine. One of the first licensed acupuncturists in the USA, he has served as President of the Florida State Oriental Medical Association, the American Association of Acupuncture and Oriental Medicine, and as Chair of the Florida Board of Acupuncture.
He is the only licensed acupuncturist ever to testify before the U.S. Senate and in 1993 was honored by the People's Republic of China for "Outstanding Contributions to the Field of Traditional Chinese Medicine." He is a member of the monthly Harvard Medical School/Massachusetts General Hospital Zoom conference on brain health. Dr. Kaltsas founded and was Dean of two Colleges of Traditional Chinese Medicine, and he annually teaches continuing education courses to hundreds of Doctors of Traditional Chinese Medicine.
He is the only licensed acupuncturist ever to testify before the U.S. Senate and in 1993 was honored by the People's Republic of China for "Outstanding Contributions to the Field of Traditional Chinese Medicine." He is a member of the monthly Harvard Medical School/Massachusetts General Hospital Zoom conference on brain health. Dr. Kaltsas founded and was Dean of two Colleges of Traditional Chinese Medicine, and he annually teaches continuing education courses to hundreds of Doctors of Traditional Chinese Medicine.
Stanley T. Lewis, MD, MPH Medical Advisor
Dr. Lewis has dedicated over 25 years to patient care, teaching, clinical research, and drug development.
Prior to founding A28 Therapeutics, Dr. Lewis served as Chief Medical Officer of Ansun Biopharma where he successfully led the company’s clinical development team to design and conduct late-stage clinical trials in parainfluenza, influenza, and COVID-19. In addition to clinical development, Dr. Lewis anchored the company’s fundraising team securing $100M in Series B financing and provided strategic leadership on in-licensing, efforts.
Before joining Ansun, Dr. Lewis was Chief Medical Officer at TaiMed Biologics where he led the company to US FDA approval of TROGARZOTM, the first monoclonal antibody treatment for multi-drug resistant HIV disease. Dr. Lewis also assisted in development, manufacturing, and commercial licensing deals while providing strategic leadership. While at TaiMed Dr. Lewis helped the company garner funding support through the Bill and Melinda Gates Foundation as well as regulatory designations including Breakthrough Therapy designation, Orphan Drug designation, and Orphan Drug grant awards for TaiMed products.
Dr. Lewis is a leader in healthcare who serves on multiple scientific and medical advisory boards as for both for-profit and non-profit organizations. Dr. Lewis is a graduate of The University of Texas Medical School-Houston where he completed his residency and fellowship in Internal Medicine. He also earned a Master’s in Public Health while serving on the faculty of his alma mater as Assistant Professor of Medicine in the Department of Internal Medicine before transitioning to the biotech industry in 2004.
Before joining Ansun, Dr. Lewis was Chief Medical Officer at TaiMed Biologics where he led the company to US FDA approval of TROGARZOTM, the first monoclonal antibody treatment for multi-drug resistant HIV disease. Dr. Lewis also assisted in development, manufacturing, and commercial licensing deals while providing strategic leadership. While at TaiMed Dr. Lewis helped the company garner funding support through the Bill and Melinda Gates Foundation as well as regulatory designations including Breakthrough Therapy designation, Orphan Drug designation, and Orphan Drug grant awards for TaiMed products.
Dr. Lewis is a leader in healthcare who serves on multiple scientific and medical advisory boards as for both for-profit and non-profit organizations. Dr. Lewis is a graduate of The University of Texas Medical School-Houston where he completed his residency and fellowship in Internal Medicine. He also earned a Master’s in Public Health while serving on the faculty of his alma mater as Assistant Professor of Medicine in the Department of Internal Medicine before transitioning to the biotech industry in 2004.
Dr. Robert Hunt Carpenter, DVM, MS Medical Advisor
Robert Hunt Carpenter DVM, MS, is currently President and CEO of Texas EnteroSorbents, Inc. (TxESI). TxESI was founded in 2005 and is the first Texas A&M University System funded biotechnology company based upon research from the College of Veterinary Medicine. Dr. Carpenter is responsible for the worldwide development of the TxESI technologies of which he is also the inventor. This novel composition of matter is the subject of three patents with uses ranging from food and feed additives, medical devices to pharmaceuticals. Dr. Carpenter also manages the worldwide regulatory program for this composition for its multiple uses in mammals.
Dr. Carpenter is a 1970 BS graduate of Texas A&M University. He received his Doctor of Veterinary Medicine degree in 1971 and a post doctorate Master of Science degree in Comparative Medicine/Laboratory Animal Medicine in 1972 also from TAMU. He served over 4 years in the U.S. Air Force at Wilford Hall U.S.A.F. Medical Center and School of Aerospace Medicine where he participated in surgical research, aircrew protection device development, and disaster medicine/survival training doctrine development.
In 1992, Dr. Carpenter became medical director of Shotwell & Carr, Inc. where he assisted clients in the development of drugs (FDA), biologics (USDA) and medical devices (FDA/CDRH) for human and veterinary use. There Dr. Carpenter compiled and helped submit the very first New Drug Application (NDA) of a new drug composition for immediate over-the-counter (OTC) distribution. This product, IvyBlock™, was approved for the OTC market in less than 18 months.
Most recently, Dr. Carpenter was Clinical and Regulatory Affairs Team Leader at ADViSYS, Inc. where he was responsible for development of the patented DNA plasmid administration system and the worldwide clinical and regulatory development of this novel DNA plasmid technology. In July of 2005 he became CEO and President of Texas EnteroSorbents, Inc. He is the inventor of TxESI Technologies including its lead drug composition, ACCS100, that just completed a Phase 2B clinical trial in San Antonio, TX for cancer prevention due to Aflatoxin exposure.
He is co-inventor and author of over 40 composition, process and use patents filed in 26 countries. He has produced numerous publications and presentations.
Dr. Carpenter is a 1970 BS graduate of Texas A&M University. He received his Doctor of Veterinary Medicine degree in 1971 and a post doctorate Master of Science degree in Comparative Medicine/Laboratory Animal Medicine in 1972 also from TAMU. He served over 4 years in the U.S. Air Force at Wilford Hall U.S.A.F. Medical Center and School of Aerospace Medicine where he participated in surgical research, aircrew protection device development, and disaster medicine/survival training doctrine development.
In 1992, Dr. Carpenter became medical director of Shotwell & Carr, Inc. where he assisted clients in the development of drugs (FDA), biologics (USDA) and medical devices (FDA/CDRH) for human and veterinary use. There Dr. Carpenter compiled and helped submit the very first New Drug Application (NDA) of a new drug composition for immediate over-the-counter (OTC) distribution. This product, IvyBlock™, was approved for the OTC market in less than 18 months.
Most recently, Dr. Carpenter was Clinical and Regulatory Affairs Team Leader at ADViSYS, Inc. where he was responsible for development of the patented DNA plasmid administration system and the worldwide clinical and regulatory development of this novel DNA plasmid technology. In July of 2005 he became CEO and President of Texas EnteroSorbents, Inc. He is the inventor of TxESI Technologies including its lead drug composition, ACCS100, that just completed a Phase 2B clinical trial in San Antonio, TX for cancer prevention due to Aflatoxin exposure.
He is co-inventor and author of over 40 composition, process and use patents filed in 26 countries. He has produced numerous publications and presentations.
Dr. Joseph Cleaver, MD, FAARM, ABAARM Medical Advisor
Dr. Cleaver is fellow of the American Board of Anti- Aging/Regenerative Medicine (ABAARM), In addition to Dr. Cleaver’s board certification in Internal Medicine (ABIM), he is board certified in anti-aging and regenerative medicine and has achieved certification by the ABAARM in Advanced Metabolic Endocrinology specializing in bio- identical hormone therapy. As a faculty member at A4M and MMI he lectures both nationally and internationally in longevity medicine, sports performance, and regenerative medicine. Board certified in internal medicine and a rheumatologist he is an expert in medical ortho-biologic treatment of sports injuries and disorders of the musculoskeletal system.
He holds the position of adjunct clinical professor at George Washington School of Medicine where he has taught the exercise prescription component of the Masters Program in Integrative Medicine. He is a past member of the scientific advisory board and board of directors for the International Peptide Society, Dr. Cleaver lectures on the use of peptides in longevity, senolytic science, aesthetics and hair restoration and actively trains medical professionals at Peptide Practices of America.
He has authored and published research and textbook chapters. While at the Cooper Clinic and Cooper Institute he has conducted NIH research, funded by Homeland Security grants, assessing the health and developing fitness programs for first responders, focusing on first responders. He has written numerous articles for several international sports and anti-aging magazines. He co-authored the exercise and muscle health chapter for the George Washington Medical School Integrative Medicine textbook. He is a master trainer at TRAIN NOW MD, a highly sought-after hands-on training program in the field of regenerative and cosmetic medicine.
He holds the position of adjunct clinical professor at George Washington School of Medicine where he has taught the exercise prescription component of the Masters Program in Integrative Medicine. He is a past member of the scientific advisory board and board of directors for the International Peptide Society, Dr. Cleaver lectures on the use of peptides in longevity, senolytic science, aesthetics and hair restoration and actively trains medical professionals at Peptide Practices of America.
He has authored and published research and textbook chapters. While at the Cooper Clinic and Cooper Institute he has conducted NIH research, funded by Homeland Security grants, assessing the health and developing fitness programs for first responders, focusing on first responders. He has written numerous articles for several international sports and anti-aging magazines. He co-authored the exercise and muscle health chapter for the George Washington Medical School Integrative Medicine textbook. He is a master trainer at TRAIN NOW MD, a highly sought-after hands-on training program in the field of regenerative and cosmetic medicine.
BOARD AND STRATEGIC ADVISORS
Dr. Leonard Makowka, Senior Strategic Advisor to the CEO and Board of Directors
Dr. Makowka is a sophisticated healthcare technology investor and world-renowned medical professional with expertise and global relationships in healthcare and healthcare technology. Dr. Makowka was a Managing Director at Innovative Technology Partners, a late-stage technology venture fund for 2 years.
During his medical career, from 1985 to 1995 Dr. Makowka was the Director of Surgery, Director of transplant Services and Chairman of the Cedar-Sinai Medical Center Department of Surgery. From 1995 to 1997, Makowka was the Executive Director of St Vincent Medical Centre Comprehensive Liver Disease and Treatment Center and Liver Transplant Program.
Dr Makowka has served on the board of Hollis Eden Pharmaceuticals (NASDAQ: HEPH) and Kinamed Inc., (biotech). He was the Chief Science Officer of Universal Detection Systems and a Founding Consultant of IVIVI Technologies (NASDAQ: IVVI).
During his medical career, from 1985 to 1995 Dr. Makowka was the Director of Surgery, Director of transplant Services and Chairman of the Cedar-Sinai Medical Center Department of Surgery. From 1995 to 1997, Makowka was the Executive Director of St Vincent Medical Centre Comprehensive Liver Disease and Treatment Center and Liver Transplant Program.
Dr Makowka has served on the board of Hollis Eden Pharmaceuticals (NASDAQ: HEPH) and Kinamed Inc., (biotech). He was the Chief Science Officer of Universal Detection Systems and a Founding Consultant of IVIVI Technologies (NASDAQ: IVVI).
Mark Timm, Board Member & Senior Strategic Advisor
Mark Timm has been a serial entrepreneur and exponential thinking practitioner for nearly two decades. He has started more than a dozen companies, several of which have multiplied and been sold, and has consequently participated in several equity events. His businesses have been built with international footprints in more than a dozen countries across diverse industries from retail to wholesale and from product manufacturing to digital marketing and real estate.
Mark is the best-selling author of Mentor To Millions and today spends his time and talents investing, advising, and serving on the board of directors for publicly traded and private companies where he can leverage his experience and relationships, achieving exponential growth and shareholder value.
Mark is the best-selling author of Mentor To Millions and today spends his time and talents investing, advising, and serving on the board of directors for publicly traded and private companies where he can leverage his experience and relationships, achieving exponential growth and shareholder value.
Kevin Harrington, Senior Strategic Advisor
An original “shark” on the hit TV show Shark Tank, the creator of the infomercial, pioneer of the As Seen on TV brand, and co-founding board member of the Entrepreneur’s Organization—Kevin Harrington has pushed past all the questions and excuses to repeatedly enjoy 100X success.
His legendary work behind-the-scenes of business ventures has produced well over $5 billion in global sales, the launch of more than 500 products, and the making dozens of millionaires. Twenty of his companies have each topped $100 million in revenue.
As a team, we are dedicated to bringing forth cutting edge products that are backed by science and formulated to support total body health.
We’d love for you to join us and so you too can “Feel The Feeling”™
As a team, we are dedicated to bringing forth cutting edge products that are backed by science and formulated to support total body health.
We’d love for you to join us and so you too can “Feel The Feeling”™
